Oncolytic Herpes Simplex Virus Vector G47Δ Effectively Targets Breast Cancer Stem Cells

被引：0
|
作者：
Liu, R.
Zeng, W.
Hu, P.
Wu, J.
Li, J.
Wang, J.
Lei, L.
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China
[2] Sichuan Prov Canc Hosp, Chengdu, Sichuan, Peoples R China
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P4-05-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-05-01
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells
    Fu, Xinping
    Rivera, Armando
    Tao, Lihua
    De Geest, Bart
    Zhang, Xiaoliu
    MOLECULAR THERAPY, 2012, 20 (02) : 339 - 346
  • [32] Oncolytic herpes simplex virus vectors for the treatment of human breast cancer
    Samuel D. Rabkin
    ChineseMedicalJournal, 2005, (04) : 307 - 312
  • [33] Oncolytic herpes simplex virus vectors for the treatment of human breast cancer
    Samuel D. Rabkin
    中华医学杂志(英文版), 2005, (04) : 307 - 312
  • [34] Oncolytic Herpes Simplex Virus Type 1 (G47Δ) Enhances the Therapeutic Efficacy of an Anti-EGFR Targeted Therapy in Murine Tumor Model
    Nagatomo, Takafumi
    Ino, Yasushi
    Iwai, Miwako
    Nishino, Hiroshi
    Todo, Tomoki
    MOLECULAR THERAPY, 2018, 26 (05) : 344 - 345
  • [35] Oncolytic herpes simplex virus vectors for the treatment of human breast cancer
    Liu, RB
    Rabkin, SD
    CHINESE MEDICAL JOURNAL, 2005, 118 (04) : 307 - 312
  • [36] Combination therapy for renal cell carcinoma using oncolytic herpes virus(G47 δ) and immune checkpoint inhibitors
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2023, 114 : 1797 - 1797
  • [37] Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
    Yajima, Shoh
    Sugawara, Kotaro
    Iwai, Miwako
    Tanaka, Minoru
    Seto, Yasuyuki
    Todo, Tomoki
    MOLECULAR THERAPY ONCOLYTICS, 2021, 23 : 402 - 411
  • [38] Combination therapy for renal cell carcinoma using oncolytic herpes virus(G47δ) and immune checkpoint inhibitors
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2023, 114 : 2172 - 2172
  • [39] Efficacy of oncolytic herpes virus G47δ combined with immune checkpoint inhibitors in renal cell carcinoma models
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2024, 115 : 648 - 648
  • [40] The efficacy of oncolytic virus therapy using G47 Δ in mouse biliary tract cancer models
    Tateno, Yoko
    Ino, Yasushi
    Iwai, Miwako
    Shinozaki, Masaru
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 1392 - 1392
12345